AKT1 and cancer: Oncogenic dysregulation of MDEs often involves oncogenic miRNAs and proteins to instigate signaling pathways in human cancer cells, e.g., PI3K/AKT or Wnt/β-catenin pathway that brings about increased cell proliferation/survival (55).